Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83

European Urology

Volumn 60, Issue 5, 2011, Pages

  Fanti, Stefano ^a   Krause, Bernd ^b   Weber, Wolfgang ^c   Castellucci, Paolo ^a   Grosu, Anca Licia ^c   De Jong, Igle J ^d   Messa, Cristina ^e   Picchio, Maria ^f   Pruim, Jan ^d   Langsteger, Werner ^g   Chiti, Arturo ^h  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g St Vincent Hospital   (Austria)

^h HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CHOLINE; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER RELAPSE; CASTRATION RESISTANT PROSTATE CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HUMAN; LETTER; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT CANCER; WHOLE BODY CT; WHOLE BODY PET;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS;

EID: 80053335505     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.08.009     Document Type: Letter

References (16)

1. N. Mottet, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 59 2011 572 583
2. E. Pelosi, V. Arena, and A. Skanjeti Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer Radiol Med 113 2008 895 904
3. M. Picchio, C. Messa, and C. Landoni Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337 1340 (Pubitemid 36323779)
4. M. Cimitan, R. Bortolus, and S. Morassut [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 2006 1387 1398 (Pubitemid 44885404)
5. B.J. Krause, M. Souvatzoglou, and M. Tuncel The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18 23 (Pubitemid 350234152)
6. G. Giovacchini, M. Picchio, and E. Coradeschi Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 301 309
7. P. Castellucci, C. Fuccio, and C. Nanni Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 2009 1394 1400
8. G. Giovacchini, M. Picchio, and A. Briganti [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging J Urol 184 2010 938 943
9. A.J. Breeuwsma, J. Pruim, and A.C. van den Bergh Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11)C-choline positron emission tomography Int J Radiat Oncol Biol Phys 77 2010 160 164
10. D.B. Husarik, R. Miralbell, and M. Dubs Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 253 263
11. Krause BJ, Souvatzoglou M, Treiber U. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates. Urol Oncol. In press. DOI:10.1016/j.urolonc.2010.08.008.
12. O. Schillaci, F. Calabria, and M. Tavolozza 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer Nucl Med Commun 31 2010 39 45
13. L. Rinnab, F.M. Mottaghy, and N.M. Blumstein Evaluation of [11C]- choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer BJU Int 100 2007 786 793 (Pubitemid 47360183)
14. 11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429 (Pubitemid 46963456)
15. S.N. Reske, N.M. Blumstein, and G. Glatting [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9 17 (Pubitemid 350234137)
16. M. Picchio, A. Briganti, and S. Fanti The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer Eur Urol 59 2011 51 60